Calculating the dose of cisplatin that is actually utilized in hyperthermic intraperitoneal chemotherapy among ovarian cancer patients

BACKGROUND: Hyperthermic intraperitoneal chemotherapy (HIPEC) is an important treatment for ovarian cancer. A certain portion of cisplatin exits the body via the perfusate at the end of HIPEC, so full-dose utilization cannot be achieved. Herein, we sought to explore how much cisplatin is actually ut...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:J Ovarian Res
Hlavní autoři: Wang, Wu-yun, Wu, Miao-fang, Wu, Dong-bing, Wang, Li-juan, Li, Hui, Lin, Zhong-qiu, Li, Jing
Médium: Artigo
Jazyk:Inglês
Vydáno: BioMed Central 2021
Témata:
Research
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7796576/
https://ncbi.nlm.nih.gov/pubmed/33419462
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1186/s13048-021-00764-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky